Boill Healthcare Holdings Limited (01246) released its monthly return for the month ended 31 December 2025. The company’s authorized share capital remained 4,800,000,000 ordinary shares at a par value of HKD 0.25 each, totaling HKD 1,200,000,000.

The number of issued shares stayed at 1,358,000,000, with no treasury shares reported. Public float requirements at a minimum 25% threshold were confirmed to have been met. The share option scheme adopted on 27 September 2023 continued to register 135,800,000 outstanding share options, with no new share issuances or other changes. There were no reported warrant issuances, convertible securities, or further share movements during the period.